Kurs & Likviditet
Beskrivning
Land | Danmark |
---|---|
Lista | Spotlight DK |
Sektor | Hälsovård |
Industri | Medicinteknik |
2022-02-01 08:41:51
Danish Curasight develops its drug candidates uTRACE and uTREAT for diagnosis and treatment of several cancer indications. BioStock recently took a closer look at the potential seen in prostate cancer, and in this article we will dive deeper into the company's ambitions within glioblastoma. With phase IIb results pending, preparations for phase III with uTRACE are being made, all while advancing the preclinical uTREAT project.
Read the full article at biostock.se:
https://www.biostock.se/en/2022/02/biostock-takes-a-closer-look-at-curasights-potential-in-brain-cancer/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se